Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2022–2027 · research · R01
Overcoming the triple threat to diversity in the health science workforce: empowering the next gen.
Shine Chang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022 · grant · Academic Research
Identification of enhancers of T-cell anti-tumor activity in PDAC using CRISPR activation screening
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2022–2027 · research · R01
Tumor cell lineage diversity and composition in gastric cancer progression and therapy resistance
Pawel K. Mazur · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022 · grant · Lung Cancer Research Foundation Pilot Grant
2022 – Lung Cancer Research Foundation Pilot Grant – University of Texas MD Anderson Cancer Center – Bingnan Zhang, MD
Bingnan Zhang · The University of Texas MD Anderson Cancer Center · funded by Lung Cancer Research Foundation
2022 · grant · Academic Research
Single-cell decoding of spatiotemporal and ecological evolution in early-stage KRAS- mutant lung cancer
Humam Kadara · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2022–2026 · research · R01
Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy
Diana S-L. Chow · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2025 · career development · K01
Provider and Patient-generated Remote Oro-Dental Health Electronic Data Capture for Algorithmic Longitudinal Evaluation and Risk-Assessment (PROHEALER)
Amy Catherine Moreno · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022 · grant · Academic Research
i-SINFOP: Integrative Systems-scale Interrogation of Neomorphic Fusion OncoProteins
Francesca Cole · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2022 · research · R01
Vimentin Phospho-Malleability is Critical for Maintaining Stemness and Metastatic Properties
Sendurai Ayyavoo Mani · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2025 · fellowship · F32
Targeting Quiescence Pathways to Overcome Chemoresistance in EVI1-Overexpressing Leukemia
Edward Ayoub · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Leveraging Hyperpolarized MRI for Precision Oncology Approaches in Head and Neck Cancer
James A Bankson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2024 · research · R21
Mitokines as new targets for fatigue induced by mitochondrial stress
Robert Dantzer · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U01
Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development
Humam Kadara · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2025 · award
A SIK2 Inhibitor, GRN-300, enhances Response to Paclitaxel and PARP Inhibitors and induces PD-L1 expression in Triple Negative Breast Cancer
Robert Bast · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2022–2029 · research · R35
Exploring DNA damage response pathways as targets for cancer therapy
Junjie Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2026 · research · R01
Enhanced Biomechanical Modeling of the Breast for Womens Health
Kristy Brock · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Preclinical optimization of ultra-high dose rate (FLASH) radiotherapy parameters for translational relevance
Emil Schueler · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2025 · research · R21
Identifying Novel Radiation Sensitizers in Cervical Cancer
Lauren Elizabeth Colbert · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Imaging-based tumor forecasting to predict brain tumor progression and response to therapy
Christopher Chad Quarles · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
DIRAS3 disrupts K-RAS clustering and signaling, enhancing autophagy and response to autophagy inhibition
Robert C Bast · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2025 · research · R01
Overcoming the triple threat to diversity in the health science workforce: empowering the next gen.
Shine Chang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
The Houston Center for Acquired Resistance Research (H-CARR)
Jeffrey Nicholas Myers · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U24
Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions
Liang Li · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2024 · research · R03
Delineation of the Role of CAMKK2 in Bone-metastatic Prostate Cancer and its Therapeutic Implications
Daniel Edward Frigo · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Targeting Small Nucleolar RNA Augments Immunotherapeutic Efficacy
Chunru Lin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022 · grant · Prevention
Project ACCESS: Increasing Access to Cervical Cancer Screening & Treatment Services in Texas
Melissa Varon · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2022–2027 · research · R37
Role of the pro-inflammatory omental microenvironment in ovarian cancer progression
Chi Lam Au Yeung · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Identification and assessment of unconventional tumor-associated antigens as potential targets for cytotoxic T-cell based immunotherapy of cancer
Patrick Hwu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · training · T32
Image Guided Cancer Therapy Training Program
Kristy Brock · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer
Moran Amit · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2025 · contract · N01
PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers-- Targeting the PARP Pathway for the Prevention of Breast Cancer
Powel Brown · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022 · award · grant
Coffee and Caffeine Metabolites and Disease Progression in Men Enrolled on Active Surveillance for Prostate Cancer
The University of Texas MD Anderson Cancer Center · funded by American Institute for Cancer Research
2022–2028 · research · R01
ROLE OF SORD IN SUGAR-MEDIATED CANCER METASTASIS
Jihye Yun · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Cancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome
Stanton Bradley Gray · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R37
Optimizing Personalized Screening and Diagnostic Decisions for Lung Cancer Based on Dynamic Risk Assessment and Life Expectancy
Iakovos Toumazis · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic Cancer
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
ROLE OF SORD IN SUGAR-MEDIATED CANCER METASTASIS
Jihye Yun · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022 · grant · LCRF and MET Crusaders Research Grant on MET-Driven Lung Cancer
2022 – LCRF and MET Crusaders Research Grant on MET-Driven Lung Cancer – University of Texas MD Anderson Cancer Center – Xiuning Le, MD, PhD
Xiuning Le · The University of Texas MD Anderson Cancer Center · funded by Lung Cancer Research Foundation
2022–2025 · research · R01
Improving emergency care and outcomes of immune-related adverse events: The immune-related emergency disposition index (IrEDi)
Cielito C Reyes-Gibby · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Imaging-based tumor forecasting to predict brain tumor progression and response to therapy
Christopher Chad Quarles · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
